What happens when you stop taking Wegovy for weight loss

Does weight always come back once you stop?

Broadly, yes — and the evidence is clear enough that it is worth stating plainly rather than softening. The STEP 1 extension study followed participants who had completed 68 weeks on semaglutide 2.4 mg and then switched to placebo. By one year after stopping, most of the weight lost had returned. On average, participants regained around two-thirds of what they had shed during treatment, as reported in the published findings referenced by the NHS medicines page for semaglutide.

The reason is straightforward, if frustrating. Semaglutide does not reset your biology; it manages it. While you take it, the medicine suppresses appetite signals, slows gastric emptying and raises feelings of fullness. Stop the medicine, and those signals return. For many people, hunger comes back stronger than they remember, partly because weight loss itself triggers compensatory hormonal changes that push appetite upward.

One common misconception is that regaining weight after stopping means treatment did not work. It did. The weight stayed off while the medicine was active. The difficulty is that obesity is a chronic condition, and like other chronic conditions (blood pressure, for instance), the benefit of treatment depends on continuing it. Framing regain as a relapse rather than a failure changes how people respond to it, and that matters for what comes next.

If stopping feels like the right step for you, understanding what happens when you stop Wegovy is a useful place to start before the conversation with your prescriber. Our Wegovy overview covers what the treatment involves across its full course.

What does your body actually go through in the weeks after your last dose?

Semaglutide has a half-life of roughly one week, which means it takes several weeks to clear the body fully after the last injection. During that window, appetite gradually increases rather than spiking overnight. Most people notice the shift within two to four weeks: portions that felt satisfying start to feel smaller, and the sense of fullness that came quickly during meals takes longer to arrive, or does not arrive at all.

Beyond hunger, there are other physiological shifts worth knowing about. Blood sugar regulation, which semaglutide also influences, may change, particularly relevant for anyone who was managing prediabetes or type 2 diabetes alongside weight management. Blood pressure and lipid levels can shift too, often improving during treatment and then moving back toward baseline after stopping. These are reasons to let your prescriber know before you stop, rather than simply not ordering a repeat.

Our page covering what happens when you stop taking Wegovy explains the physiological picture in full, including the hormonal mechanisms involved. For side-effect questions specifically, the MHRA Yellow Card scheme allows patients to report unexpected effects after stopping as well as during treatment.

Is there a safer way to stop, or does it matter how you come off?

There is no established clinical tapering protocol for semaglutide the way there is for some other medicines, you do not technically need to step down through doses before stopping. That said, stopping mid-titration versus stopping at full maintenance dose does make a practical difference: the higher the dose you were taking, the more pronounced the return of appetite signals tends to be.

What matters most is what you have in place when you stop. Structured lifestyle support (a dietary pattern that accounts for returning hunger, regular physical activity already embedded in your routine, and ideally some input from a dietitian or health coach) meaningfully slows the rate of regain. People who stop abruptly with nothing in place tend to regain faster than those who plan the exit with their clinical team.

If cost is the reason you are considering stopping, it is worth looking at how Wegovy pricing compares across UK providers before making a final decision, since prices and what they include vary considerably. For those considering a short break rather than stopping permanently, the question of what a two-week pause does to treatment progress is answered separately.

What are the options if you do not want to stop but feel you have to?

This is the question our prescribers hear most often from people who are partway through a course and running into a barrier, cost, a change in circumstances, or uncertainty about how long to continue. It is worth knowing what the realistic options are before stopping becomes the default.

Some people move to a lower maintenance dose rather than stopping entirely, which can reduce cost while retaining some of the appetite effects, though with less pronounced weight management. Others pause treatment for a defined period with a plan to restart, which carries regain risk but is preferable to stopping without any plan at all. If you are weighing up longer-term implications, our page on what happens after you stop taking Wegovy covers what to expect in the months that follow, including how to approach weight maintenance. A small number of patients transition to a different licensed treatment following a clinical review; our prescribers can discuss whether that makes sense for your situation.

The honest point is that weight management medicines work best as part of a longer-term plan, not a fixed course. Speak to our clinical team about what continuing, pausing or stopping realistically looks like for you, and explore the full range of options on our treatments page before deciding. If you have wider questions, our FAQs may help too.